Abstract In addition to its high frequency and relevant individual and social impact, chronic pain (CP) has been shown to be a major contributor to increased healthcare utilisation, reduced labour productivity, and consequently large direct and indirect costs. In the context of a larger nationwide study, we aimed to assess the total annual direct and indirect costs associated with CP in Portugal. A population-based study was conducted in a representative sample of the Portuguese adult population. The 5,094 participants were selected using random digit dialling and contacted by computer-assisted telephone interviews. Questionnaires included the brief pain inventory and pain disability index. Estimates were adequately weighted for the population. From all CP subjects identified, a subsample (n = 562) accepted to participate in this economic study. Mean total annualised costs per CP subject of €1,883.30 were observed, amounting to €4,611.69 million nationally, with 42.7 % direct and 57.3 % indirect costs, and corresponding to 2.71 % of the Portuguese annual GDP in 2010. Only socio-demographic variables were significantly and independently associated with CP costs, and not CP severity, raising the possibility of existing inequalities in the distribution of healthcare in Portugal. The high economic impact of CP in Portugal was comprehensively demonstrated. Given the high indirect costs observed, restricting healthcare services is not a rational response to these high societal costs; instead improving the quality of CP prevention and management is recommended.
Introduction
Chronic pain (CP) is a major public health issue with important individual consequences and high socio-economic burden [1] [2] [3] [4] . Chronic pain has clearly reached epidemic proportions worldwide and its economic costs have been shown to be exceedingly high [4] [5] [6] [7] [8] [9] [10] , with some authors even claiming that CP could significantly contribute to ''the end of the welfare state'' [9] . Pain due to musculoskeletal disorders and chronic low back pain (CLBP) has been shown to represent, in European countries, costs of up to 2 % of the national gross domestic product (GDP) per year [10, 11] .
Some studies have estimated the costs of CP, but estimates are inconsistent, mostly because of differences in methodology, costs considered, and populations [8] . Many studies focussed on particular CP subpopulations [1, 8, [12] [13] [14] [15] or particular healthcare settings [16] [17] [18] [19] . Some studies have specifically estimated only direct [6, 17] or indirect costs [20, 21] , and costing methods have been inconsistent [8] .
To the best of our knowledge, there are only two recently published population-based studies having estimated direct and indirect costs of CP in general (and not condition or setting specific), with comprehensive and explicit cost methodologies. One of those studies found annual CP costs per patient of €5,665 in Ireland [22] , while the other €6,400 in Sweden [23] .
In Portugal, there are no adequate population-based estimates available of the total (direct and indirect) costs of CP in general. The only additional Portuguese study [21] found an estimate of the indirect costs of CLBP in Portugal of €739.85 million. Although methodologically sound, this was a condition-specific study (having only considered the CLBP population, which represents only around 42 % of CP subjects in Portugal [24] ), it was focussed on indirect costs, and they used indirect methods to derive the costs of long-term productivity losses and not direct subject's reports.
Therefore, in the context of a large population-based study, specifically designed to assess the CP epidemiology and impact in Portugal [24, 25] , our aim was to assess the total annual costs associated with CP in general, including estimates for direct and indirect costs and using comprehensive and explicit costing methods.
Methods

Study design
This was a cost-of-illness study, with a societal perspective, using a bottom-up approach for cost estimation and based on a representative subsample of chronic pain (CP) subjects, selected from a larger cross-sectional nationwide study aiming to assess CP epidemiology and impact [24, 25] .
Participants and data collection A cross-sectional nationwide epidemiological study was conducted in a representative sample of the Portuguese population (n = 5,094), using random digit dialling (RDD) and computer-assisted telephone interviews (CATI). Details regarding the study design, measures, and methods used have been presented elsewhere [24, 25] . The study was approved by an institutional review board and all subjects gave their informed consent for participation. Standard criteria from the International Association for the Study of Pain (IASP) were used for CP definition and screening [26] . Chronic pain is defined by IASP as pain reported as persisting for more than 3 months, regardless of the cause and persistence pattern [26] . We operationalised this definition accordingly. Two screening questions were used as follows: (1) respondents were initially asked about whether or not they generally had pain [''Throughout our lives, most of us have had pain from time to time (such as minor headaches, sprains, and toothaches). Other than these everyday kinds of pain, are you currently troubled by physical pain, either all the time, or on and off?'']; (2) then a question was asked about pain duration (''For how long have you had this pain problem?''). Subjects were defined as having chronic pain if they answered the first question positively and had pain duration of more than 3 months.
Subsequently, subjects reporting recurrent or continuous chronic pain were invited to participate in a second phase of the study; those accepting constituted the final subsample (n = 562) of the present economic study (please see supplementary Table 1S ). The goal was to obtain a sample size of at least 500 subjects in this second phase, in order to warrant the estimation of mean costs with margins of error less than 10 % of the assumed population standard deviations and a 95 % confidence level and taking into account the expected skewed distributions of the cost variables. This second phase included an additional structured questionnaire assessing in more detail healthcare resource use and issues regarding indirect costs of CP [27] .
Cost estimation methods
Direct healthcare costs were calculated for each patient by adding the costs of pain medicines, non-pharmacologic pain treatment modalities, medical consultations in primary care and hospital settings, consultations with other healthcare professionals, and medical tests performed [27] . Amounts of resources used for each cost item were estimated based on responses to the structured questionnaire. Costs for each item and for each subject were calculated multiplying the amount of resources used by the unit costs of the resource. Unit costs were obtained from official national average tariffs, using official national statistics, hospital management and accounting reports [28] , national costs lists of diagnosis-related groups [29] , and the national drug formulary [30] . If no official tariffs existed, average market prices were used. In those instances we used, as the best estimate available, the average of three market prices for the item obtained after searching and contacting (online or by telephone) at least three different companies providing those services. This is a standard method used in these situations and it gives us at least a very good approximation of the ''true'' pricing of those items. All costs were used or converted to 2010 prices in euros (€) [31] .
Based on the human capital method, indirect costs associated to productivity losses due to work absenteeism, early retirement, and job loss [27] were calculated on an annual basis and based on the number of lost work days of the active population and the national average daily income for the subject-specific occupational class. The average monthly net incomes for different occupational classes for the year 2010 were obtained from the Portuguese National Institute of Statics (Instituto Nacional de Estatística-INE) [32] and were corrected by adding the corresponding taxes and welfare shares. These corrected monthly incomes were multiplied by 14, accounting for 12 months work plus two annual subsidies; the total was then divided by 230 to obtain the monetary value of the productivity of 1 day of work. To calculate productivity losses due to absenteeism, the annual number of lost work days reported by each subject was multiplied by his/her specific monetary value of 1 work day. To calculate productivity losses due to early retirement and job losses, the annual values of the pensions for each subject were considered for persons that would otherwise be part of the active working population. Although potentially relevant [27] , other sources of indirect costs were not considered.
Statistical analysis
Taking into account the study aims, the statistical analysis included appropriate descriptive and inferential statistics. General characteristics of the studied sample were described and comparisons with the total sample of CP subjects from the first phase of the study were performed in order to assess potential selection bias.
Cost variables were all annualised and are described with the corresponding mean, standard deviation (SD), median, and percentiles [25th (P25) and 75th (P75)]. Because cost variables had very skewed distributions, 95 % confidence intervals (95 % CI) for the means were calculated using bootstrap methods [27, 33, 34] . The software used to calculate the bootstrap CIs was R version 3.0.1 [35] . For each cost category, extrapolated estimates for the Portuguese population were also calculated. Extrapolation estimates were based on a prevalence estimate of recurrent or continuous CP of 29.6 % (95 % CI 28.2-30.9) [24] . Estimates of costs for each sex and age strata are also presented and were based on strata-specific prevalence, population size [36] , and mean costs. Lastly, the analysis of the cumulative ordered proportion of the total costs was performed to assess the skewness of cost distribution.
Because we were unable to obtain primary data for all participants regarding hospital inpatient care costs, we additionally used decision analytic modelling to perform univariate deterministic sensitivity analysis, in order to evaluate how the inclusion of these costs would impact the estimates of national annualised costs of CP in Portugal. We took into account the proportion of total CP costs associated with hospital inpatient care described in the two more recent and similar studies performed in European countries-Ireland and Sweden [22, 23] . To define the range of variation and the parameter value for the base case scenario, we assessed the estimates presented in each study. In the Irish study the hospital inpatient care was found to represent 21.5 % of the total costs of CP; in the Swedish study it represented 14 % of the total costs. Thus, we considered 10-25 % as the most sensible range of variation for this parameter and we used the mean of both studies (18 %) as the base case scenario.
After the descriptive analysis, factors associated with total costs were assessed using generalised linear models (GLMs), following current international recommendations [37] . Mixed Poisson-gamma models were used (defining a Tweedie distribution family model and a log link function) [38] [39] [40] [41] for three main reasons: first, because of the skewed distribution and overdispersion of the costs variables. Second, this approach provides potentially more robust estimators than alternative models such as ordinary least squares (OLS) regression for log normal [39] . Third, because there were several subjects with zero costs, a single-equation GLM was sought allowing for a non-zero probability of zero values [38] . In this case, the GLM with a mixed Poisson-gamma (Tweedie) distribution [38] [39] [40] [41] has been shown to be an adequate alternative [37-39, 41, 42] . Univariate and multivariate models are presented. In the multiple GLM regression models, goodness of fit was evaluated and the influence of outlier data values and collinearity was also assessed. Model results are presented as the exponential of the model coefficients (interpreted as ratios of geometric means) and its 95 % CI.
For all statistical hypothesis tests a significance level of a = 5 % was assumed. Unless otherwise indicated, the statistical analyses were performed using the software SPSS 20.0
Results
In the first phase of this study, a total of 5,094 randomly selected subjects from the Portuguese adult population accepted to participate. The observed prevalence of CP for the Portuguese adult population, according to the IASP definition, was 36.7 % (95 % CI 35.3-38.2). The prevalence of recurrent or continuous CP was 29.6 % (95 % CI The economic impact of chronic pain 89
28.2-30.9) and all these subjects were invited to participate in the second phase of the study. The general characteristics of the subsample (n = 562) participating in this costof-illness study and the comparison with the complete sample of CP subjects pertaining to the first phase are presented in Table 1 . No significant differences were found for sex and marital status distributions, but the differences regarding age groups, professional status, and educational level were significant. No significant differences existed for pain-related disability and pain intensity (at its worst and right now), but significant differences in pain duration, persistence pattern, and intensity (at its least and on average) were observed. Estimates of mean annualised costs for each cost category are presented in Table 2 In Fig. 1 , the estimates of costs extrapolated for the Portuguese population for sex and age strata are presented. Costs are consistently higher in the 45-54-and the 55-64-year strata for both sexes. It is interesting to notice that direct costs are higher than indirect costs in the extremes; however the contrary happens for the 45-54-and the 55-64-year strata. Moreover, it is possible to observe that costs for females are consistently higher than those for males across age strata.
In relation to the estimates of indirect costs presented, it is relevant to notice that the observed annualised mean of lost work days among subjects of the active population in the subsample studied was 11.76 (SD 37.79). The larger estimates were found among the subjects in the 35-44 years age group (mean 15.67 and SD 48.86), 45-54-year age group (mean 16.49 and SD 47.73), and 55-64-year age group (mean 9.66 and SD 22.03). Additionally, the percentage of subjects reporting early retirements associated with chronic pain was 13.7 % (n = 77): from those, the percentage of persons that would otherwise currently be part of the active working population was 45.5 % (n = 35). Finally, the percentage reporting job loss in relation to their chronic pain problem was 5.3 % (n = 30); from those, 36.7 % (n = 11) were currently unemployed, looking for a job, and would otherwise be part of the active working population.
In Fig. 2 , the cumulative ordered percentage of the total annualised costs was analysed and plotted. It is interesting to observe that, when considering the ordered total annualised costs, the top 10 % of the subjects are responsible for 63 % of the total CP costs, and the top 27 % of the subjects are responsible for 80 % of the total costs.
Because we were unable to obtain primary data for all participants regarding hospital inpatient care costs, we additionally used decision analytic modelling to perform univariate deterministic sensitivity analysis in order to evaluate how the inclusion of these costs would impact the estimates of the national annualised costs of CP in Portugal (see ''Methods''). In the base case scenario the estimate for the mean of annualised costs per subject associated with hospital inpatient care was €413.41 (considering the range of variation of the parameter, this estimate may vary between €209.26 and €627.77), and the adjusted estimates for the mean of annualised costs per subject were €1,220.78 for direct costs (varying between €1,016.63 and €1,435.14) and €2,301.30 for total costs (varying between €2,097.15 and €2,515.66). The extrapolations of these estimates for the Portuguese population amount to €1,012.32 million for hospital inpatient care costs (varying between €512.41 and €1,537.23), €2,989.36 million for the total annualised direct costs (varying between €2,489.45 and €3,514.26), and €5,635.26 million for the total costs (varying between €5,135.35 and €6,160.17). In this hypothetical base case scenario, direct costs represented 53.0 % and indirect costs 47.0 % of the total costs, corresponding to 1.76, 1.55, and 3.31 % of the Portuguese annual GDP in 2010, respectively. In Table 3 it is possible to observe the heterogeneous distribution of the total annualised mean costs of CP, with relevant variations in relation to demographic and socioeconomic variables, pain characteristics, and severity and psychological distress factors. Higher estimates were observed among females, the 45-54-and 55-64-year age groups, those divorced or separated, unemployed or retired, those with a basic education level, lower monthly income, higher levels of pain persistence, intensity, disability and duration, pain location in the head and upper limbs, and those with previous diagnosis of depression or depressive/ anxiety symptoms.
Finally, the factors associated with total annualised CP costs were assessed using mixed Poisson-gamma models, and the results are presented in Table 3 . It was possible to show significant crude associations between total annualised costs of chronic pain and the following variables: sex, age groups, marital status, professional/occupational status, education level, monthly family income level, pain located in the head (migraine and other chronic headaches), pain located in the upper limbs, a previous medical diagnosis of a depressive disorder, presence of depressive symptoms, and presence of anxiety symptoms. However, in the final multivariate model, and when adjusted for the effects of other variables, only age groups, professional/occupational status, and education level had significant and independent associations with total annualised costs of chronic pain.
Discussion
Chronic pain has clearly reached epidemic proportions worldwide and its economic costs have been shown to be exceedingly high [4] [5] [6] [7] [8] [9] [10] , with some authors even claiming that CP could significantly contribute to ''the end of the welfare state'' [9] . Several reports, including the Institute of Medicine in its seminal 2011 report ''Reliving Pain in America'', indicate direct and indirect costs of CP in the US estimated around $100 billion per year [43] [44] [45] . Compared with other disease states the costs of CP are far greater. For example, a study performed in a large American HMO found that costs of CP were approximately $28 million more than the costs associated with heart disease, $86 million more than hypertension, and $108 million more than respiratory diseases [43, 46] . Evidence of such high costs of CP is currently available for many other Table 2 Estimates of annualised direct, indirect, and total costs (in euros, €) associated with chronic pain (n = 562) and extrapolation for the Portuguese population (in million euros) 
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P25 and P75 25th and 75th percentiles a For each cost item, the mean of the costs are calculated taking into account the values for each individual of the sample; consequently the means of the total costs are close to but not exactly the sum of the means of each cost item b Confidence intervals for the mean were calculated using bootstrap methods (see ''Methods'' section) c Estimated total annualised costs for the Portuguese population were calculated using extrapolation from the estimates of the mean and 95 % confidence intervals for the mean, taking into account the adult population size as defined by the Portuguese National Institute of Statistics (INE) and the total number of chronic pain subjects in the adult Portuguese population as defined by the prevalence estimates described (29. This was the first study in Portugal estimating the total (direct and indirect) costs of chronic pain (CP) in the general adult population. It importantly adds to the available evidence showing the high economic burden of CP [4] [5] [6] [7] [8] [9] [10] , and it is one of the very few studies available presenting CP cost estimates that are nationwide, populationbased, including direct and indirect costs, and including CP subjects in general (and not disease or location specific).
This study had some major strengths worth noting. First, it was purposely aimed and designed to study CP epidemiology and economic impact. Second, rigorous sampling methods were implemented, a large sample size was studied, and standardised definitions and validated measures were used. Third, CP subjects were studied in general and not within specific diagnosis or pain locations. Fourth, comprehensive and appropriate costing methods were implemented, including direct and indirect costs. Fifth, this was a population-based nationwide study, thus overcoming the common limitations of economic studies generating population estimates based on pain clinic or hospital-based samples and furthermore allowing improved generalisability and comparability with other country-level studies.
The high economic impact of CP in Portugal was demonstrated, with mean total annualised costs per CP subject of €1,883 and a national total of €4,612 million per year, which corresponds to 2.71 % of the Portuguese GDP, with indirect costs amounting to 57.3 % of the total. Moreover, these are probably underestimations because in the present study some other relevant sources of indirect costs (presenteeism, family and carers productivity loss, etc.) were not considered [27] . These estimates for Portugal are in general lower than those reported for other European countries. For example, two similar recently published population-based studies in Ireland [22] and Sweden [23] estimated the total annualised costs of CP per subject in €5,665 and €6,400, respectively, accounting for 2.86 and 10.0 % of the national GDPs, respectively. In both studies, indirect costs amounted to around half of the total costs, with percentages of 48 and 59 %, respectively, and in accordance with other comparable reports [47] . However, some other studies have found percentages of indirect costs relevantly higher (from 70 to 90 %) [14, 48] . It is important to notice though that international comparisons of costs should always be performed with great caution, because there are important differences among countries regarding the GDP per capita, mean income levels, welfare systems policies, average health service tariffs, and market prices and many other important aspects that may relevantly impact costs estimates [49, 50] . The lower crude estimates Fig. 1 Annualised direct, indirect, and total costs extrapolated for the Portuguese population (in million euros) for sex (solid lines for females and dashed lines for males) and age strata Fig. 2 Cumulative percentage of total chronic pain costs in the studied subsample
The economic impact of chronic pain 93 found for Portugal are probably due to these factors and in part also due to some limitations of the present study, but it should be noticed that, in relation to the national GDPs, the Portuguese estimates are very close to those in Ireland [22] and are in accordance with previously reported estimates of up to 2 % of GDP per year [10, 11] . When comparing our estimates with those of the only additional Portuguese study [21] , which looked specifically at indirect costs of CLBP in Portugal, it is interesting to see that the estimates are actually very consistent. Gouveia et al. [21] found annual indirect costs of €739.85 million, equating to a mean of €858 per subject, when averaging over the assumed number of CLBP subjects in the population. Unlike the present study, they have only considered CLBP (which represents only around 42 % of CP subjects in Portugal) [24] , they assumed lower CLBP prevalence, and they used indirect methods to derive the costs of longterm productivity losses and not direct subject's reports. Differences in the estimates are indeed accounted for by the different CLBP prevalence assumed and the fact that they studied only CLBP and not the total CP population, explaining why the estimates of mean annualised indirect costs per CP subject are actually very similar in both studies (€1,081 vs. €858). Previous reports have described higher CP costs in relation to sex, age, vulnerable subpopulations, and higher levels of pain severity [17-19, 22, 23] and a typical skewed distribution of costs [22, 23] . In the present study we found high heterogeneity among subjects regarding CP costs. Higher mean total costs were observed among females, 45-64-year age groups, vulnerable subpopulations (unemployed, lower education levels, and lower income levels), subjects with higher pain severity, and those with higher psychological distress. These findings may be an expected consequence of the particular characteristics of vulnerable populations, which puts them at higher risk of adverse health events, pain, and the associated healthcare service utilisation and costs. For the subgroups of females and those with ages between 45-64 years, these findings are explained by their higher frequency of pain and, particularly, chronic pain. For those with the most severe pain and higher psychological distress, these findings are explained by the higher use of health services typical of these subgroups as a consequence of the severity of pain and the affective components associated with pain (anxiety and depression) [17] [18] [19] .
Also the distribution of costs was particularly skewed, with the top 10 % costliest subjects accounting for 63 % of CP costs and the top 27 % accounting for 80 % of total costs. The high impact of the few most expensive patients is a common finding in this context, for example, the Irish study previously mentioned [22] performed a similar analysis and found that the top 10 % most expensive patients were responsible for 42.8 % of all costs and the top 20 % accounted for 64 % of all costs.
Reports analysing factors associated with CP costs (most of them in CLBP populations) have found significant associations with pain severity [12, 15, 22, 23, 47] as well as psychological distress factors [18, 22] , health status or quality of life [18] , and socio-economic (marital, professional, and education status) [18, 47] and demographic (age and sex) [15, 22, 47] variables. When assessing the factors associated with total annualised CP costs in Portugal, it was possible to show significant crude associations with demographic and socio-economic factors, pain location, and psychological distress. However, in the final multivariate model, and when adjusted for the effects of other variables, only age, professional/occupational status, and education level had significant and independent associations. This is an unusual finding, because most studies have found significant associations with pain characteristics and pain severity. This is also a worrying result as it raises the possibility of existing inequalities in the distribution of healthcare resources in relation to socio-economic factors in Portugal. If those inequalities did not exist, it would be expectable that pain characteristics and severity would be more strongly, independently, and significantly associated with CP costs.
Finally, this study has some limitations that deserve a particular mention and should be taken into account when interpreting its results. First, the subsample of subjects analysed had some significant differences when compared to the total sample of CP subjects assessed in the first phase of the study, in particular regarding age, professional/ occupational status, and education level. This raises the concern of some degree of overestimation due to selection bias affecting the estimates presented. However, the nonsignificant differences found regarding most pain characteristics and severity variables are reassuring and indicate that the eventually existing bias probably has a small effect.
Second, the cost estimation model for the direct costs could not include estimates of costs associated with hospital inpatient stays and surgeries because of operational limitations. This definitely influenced the estimates of direct costs. Taking into account results from other similar reports [22, 23] , costs could have been between 14 and 25 % higher if those items had been adequately accounted for. Thus, estimates of direct costs presented should be interpreted with caution and in view of this underestimation effect. In order to assess the impact of this limitation, we used decision analytic modelling to perform univariate deterministic sensitivity analysis to evaluate how the inclusion of hospital inpatient care costs would impact our estimates. We showed that, if those costs were considered, the annualised CP costs for the Portuguese population amounted to €2,989.36 million for direct costs and €5,635.26 million for total costs, with direct costs representing 53.0 % of the total, corresponding to 1.76 % of the GDP, and with total costs amounting to 3.31 % of the GDP. Thus, the inclusion of hospital inpatient care costs was indeed shown to have a moderate impact on the estimates of CP costs.
Third, multiple hypothesis tests have been presented, and because of the exploratory nature of this study no corrections for multiple comparisons have been used; thus, the results of hypothesis testing should be carefully interpreted and confirmed.
Fourth, the results regarding causal associations should be interpreted with caution, because the cross-sectional nature of this study does not allow definitely establishing causality.
In conclusion, and taking into account the limitations presented, this study, using validated measures and procedures and a comprehensive cost estimation model, showed the relevantly high economic impact of CP in Portugal.
Although cost-of-illness studies are not intended to define priorities regarding resources allocation, this study allowed us to adequately describe the major economic impact of CP. Given the demonstrated large share of indirect costs associated with CP, it is clear that restricting healthcare services is probably not the most rational response to the very high societal costs of CP. Indeed there is evidence showing that the high indirect costs of CP can be significantly reduced if patients are adequately managed in multidisciplinary rehabilitation programmes [2, 5, 44, 51] . It seems clear that the aim should be then to improve the quality of health services and healthcare professional education in order to improve the quality of CP prevention and management and to reduce the relevant impact of CP on short-and long-term work productivity losses. Moreover, investing in more and better research, which could help us tackle these challenges, is strongly recommended and may result in significant benefits for the patients and significant economic savings for the society.
